Edgestream Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.93M | Sell |
8,720
-6,713
| -43% | -$1.86M | 0.06% | 533 |
|
|
2026
Q1 | $4.56M | Buy |
15,433
+2,535
| +20% | +$753K | 0.15% | 254 |
|
|
2025
Q4 | $3.52M | Buy |
12,898
+10,709
| +489% | +$2.91M | 0.1% | 373 |
|
|
2025
Q3 | $591K | Sell |
2,189
-1,311
| -37% | -$357K | 0.02% | 708 |
|
|
2025
Q2 | $965K | Buy |
+3,500
| New | +$952K | 0.03% | 648 |
|
|
2024
Q2 | – | Sell |
-3,147
| Closed | -$678K | – | 870 |
|
|
2024
Q1 | $678K | Sell |
3,147
-2,078
| -40% | -$437K | 0.03% | 588 |
|
|
2023
Q4 | $1.1M | Buy |
5,225
+3,669
| +236% | +$783K | 0.08% | 417 |
|
|
2023
Q3 | $312K | Buy |
1,556
+293
| +23% | +$58.2K | 0.02% | 703 |
|
|
2023
Q2 | $234K | Buy |
+1,263
| New | +$233K | 0.02% | 666 |
|
|
2022
Q3 | – | Sell |
-1,740
| Closed | -$356K | – | 471 |
|
|
2022
Q2 | $356K | Sell |
1,740
-3,386
| -66% | -$718K | 0.03% | 437 |
|
|
2022
Q1 | $1.22M | Buy |
+5,126
| New | +$1.2M | 0.1% | 295 |
|
|
2021
Q4 | – | Sell |
-21,087
| Closed | -$4.08M | – | 492 |
|
|
2021
Q3 | $4.08M | Sell |
21,087
-26,806
| -56% | -$5.43M | 0.25% | 137 |
|
|
2021
Q2 | $10.2M | Buy |
47,893
+21,933
| +84% | +$4.63M | 0.6% | 39 |
|
|
2021
Q1 | $5.3M | Buy |
25,960
+11,251
| +76% | +$2.22M | 0.3% | 135 |
|
|
2020
Q4 | $2.68M | Sell |
14,709
-96,167
| -87% | -$16.4M | 0.13% | 194 |
|
|
2020
Q3 | $18.6M | Sell |
110,876
-69,774
| -39% | -$11.8M | 1.2% | 14 |
|
|
2020
Q2 | $29.4M | Buy |
180,650
+68,550
| +61% | +$12.3M | 1.54% | 10 |
|
|
2020
Q1 | $19.4M | Sell |
112,100
-38,122
| -25% | -$7.59M | 1.79% | 7 |
|
|
2019
Q4 | $30.2M | Buy |
150,222
+127,017
| +547% | +$26.1M | 1.57% | 6 |
|
|
2019
Q3 | $4.9M | Buy |
23,205
+7,393
| +47% | +$1.54M | 0.47% | 73 |
|
|
2019
Q2 | $3.07M | Sell |
15,812
-32,584
| -67% | -$6.01M | 0.35% | 94 |
|
|
2019
Q1 | $7.96M | Buy |
48,396
+39,192
| +426% | +$6.93M | 1.17% | 24 |
|
|
2018
Q4 | $1.73M | Sell |
9,204
-41,831
| -82% | -$7.72M | 0.3% | 106 |
|
|
2018
Q3 | $8.69M | Buy |
51,035
+48,569
| +1,970% | +$8.18M | 1.48% | 8 |
|
|
2018
Q2 | $404K | Buy |
+2,466
| New | +$403K | 0.08% | 210 |
|
|
2018
Q1 | – | Sell |
-1,715
| Closed | -$250K | – | 250 |
|
|
2017
Q4 | $250K | Buy |
+1,715
| New | +$244K | 0.3% | 76 |
|
|
2017
Q3 | – | Sell |
-2,745
| Closed | -$344K | – | 125 |
|
|
2017
Q2 | $344K | Buy |
+2,745
| New | +$328K | 0.13% | 105 |
|
Other funds holding CME
Edgestream Partners's CME Position: Q2 2026 in Review
Edgestream Partners reduced its CME Group (CME) stake by 43% in Q2 2026, selling an estimated $1.86M and leaving 8,720 shares worth $1.93M. The position accounts for 0.06% of the portfolio, ranked #533.
Edgestream Partners first reported a position in CME in Q2 2017 and has held it in 27 quarters since. The position peaked at $30.2M in Q4 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Edgestream Partners held 8,720 shares of CME Group worth $1.93M as of Q2 2026.
- Edgestream Partners sold 6,713 CME Group shares in Q2 2026, an estimated $1.86M.
- CME Group made up 0.06% of Edgestream Partners's portfolio in Q2 2026, its #533 holding.
- Edgestream Partners first reported a position in CME Group in Q2 2017 and has held it in 27 quarters since.
- Edgestream Partners's CME Group position peaked at $30.2M in Q4 2019.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.